글로벌 그레이브스병 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 그레이브스병 치료 시장

그레이브스병 치료 시장은 2021년에서 2028년까지의 예측 기간 동안 4.50%의 시장 성장을 목격할 것으로 예상됩니다. 그레이브스병 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 요오드 장애 및 갑상선 종양 검진의 증가는 그레이브스병 치료 시장의 성장을 가속화하고 있습니다.

그레이브스병은 갑상선의 자가면역 질환으로 갑상선 기능 항진증, 즉 갑상선 호르몬의 과다 생산을 유발합니다. 면역 체계가 갑상선을 공격하여 부종을 유발하여 갑상선이 과활성화되고 갑상선 호르몬이 과도하게 생성 됩니다 .

예측 기간 동안 그레이브스병 치료 시장 성장을 촉진할 것으로 예상되는 주요 요인은 그레이브스병 및 하시모토 갑상선염과 같은 자가면역 질환 의 발생률 증가입니다 . 또한, 이러한 질환에 대한 인식을 높이는 갑상선 질환에 대한 여러 국가적 건강 프로그램은 그레이브스병 치료 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 반면, 갑상선 질환 치료를 위한 치료와 대체 의약품의 사용과 관련된 가격의 상승은 그레이브스병 치료 시장의 성장을 더욱 완화할 것으로 추정됩니다.

또한, 치료에 대한 적절한 환불 정책은 향후 몇 년 동안 그레이브스병 치료 시장 성장에 대한 잠재적 기회를 더욱 제공할 것입니다. 그러나 엄격한 정부 규제는 가까운 미래에 그레이브스병 치료 시장 성장에 더욱 도전할 수 있습니다.

The graves disease treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the graves disease treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Graves Disease Treatment Market Scope and Market Size

Regenerative medicine market is segmented on the basis of mechanism of action, drugs, treatment, route of administration, distribution channel and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of mechanism of action, the graves disease treatment market is segmented into anti-thyroid agents, beta blockers, corticosteroids and others.
• On the basis of drugs, the graves disease treatment market is segmented into propylthiouracil, methimazole, propranolol, prednisone and others.
• On the basis of treatment, the graves disease treatment market is segmented into medication, radioactive iodine therapy, surgery and others.
• On the basis of route of administration, the graves disease treatment market is segmented into oral, intravenous and others
• On the basis of distribution channel, the graves disease treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy
• On the basis of end users, the graves disease treatment market is segmented into hospitals, homecare, specialty clinics, others.

Graves Disease Treatment Market Country Level Analysis

The graves disease treatment market is analysed and market size information is provided by country, mechanism of action, drugs, treatment, route of administration, distribution channel and end users as referenced above.

The countries covered in the graves disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the graves disease treatment market due to the rise in the thyroid related disorders. Furthermore, the increase in the in awareness about hyperthyroidism will further boost the growth of the graves disease treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the graves disease treatment market due to the thyroid related disorders drugs because of the increase in the health care investments. Moreover, the increase in the consciousness about hyperthyroidism is further anticipated to propel the growth of the graves disease treatment market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Regenerative medicine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Graves Disease Treatment Market Share Analysis

The graves disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to graves disease treatment market.

그레이브스병 치료 시장 보고서에 포함된 주요 기업으로는 Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan NV, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Lupin Pharmaceuticals Inc., Bayer AG, Lupin Pharmaceuticals Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 그레이브스병 치료 시장 점유율 데이터는 글로벌, 북미, 남미, 유럽, 아시아 태평양(APAC) 및 중동 및 아프리카(MEA)에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46204